Caroline M Mitchell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vagina | 56 | 2024 | 841 | 13.240 |
Why?
|
Vaginosis, Bacterial | 26 | 2024 | 151 | 8.160 |
Why?
|
Postmenopause | 23 | 2024 | 2514 | 5.720 |
Why?
|
Lactobacillus | 25 | 2024 | 212 | 5.580 |
Why?
|
Vaginal Diseases | 14 | 2023 | 103 | 5.320 |
Why?
|
Estradiol | 13 | 2024 | 1937 | 2.880 |
Why?
|
Menopause | 15 | 2024 | 1646 | 2.790 |
Why?
|
Cervix Uteri | 8 | 2021 | 570 | 2.110 |
Why?
|
Estrogens | 11 | 2023 | 1522 | 1.930 |
Why?
|
Pelvic Inflammatory Disease | 3 | 2021 | 96 | 1.890 |
Why?
|
Vaginal Creams, Foams, and Jellies | 6 | 2022 | 62 | 1.830 |
Why?
|
Vaginitis | 3 | 2024 | 49 | 1.790 |
Why?
|
RNA, Ribosomal, 16S | 11 | 2024 | 1032 | 1.510 |
Why?
|
Female Urogenital Diseases | 3 | 2024 | 57 | 1.380 |
Why?
|
Metronidazole | 8 | 2024 | 232 | 1.200 |
Why?
|
Gardnerella vaginalis | 5 | 2016 | 20 | 1.200 |
Why?
|
Lasers, Gas | 2 | 2020 | 101 | 1.170 |
Why?
|
Vulvar Diseases | 5 | 2020 | 64 | 1.130 |
Why?
|
Probiotics | 3 | 2020 | 378 | 1.090 |
Why?
|
Vaginal Douching | 5 | 2021 | 17 | 1.080 |
Why?
|
HIV-1 | 12 | 2020 | 6851 | 1.060 |
Why?
|
Virus Shedding | 4 | 2020 | 109 | 0.990 |
Why?
|
Escherichia coli | 4 | 2021 | 4201 | 0.990 |
Why?
|
Premenopause | 3 | 2021 | 1039 | 0.980 |
Why?
|
Estrone | 3 | 2022 | 234 | 0.960 |
Why?
|
Vaginal Discharge | 3 | 2021 | 25 | 0.950 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 2024 | 25 | 0.940 |
Why?
|
Dyspareunia | 3 | 2019 | 48 | 0.830 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2021 | 2477 | 0.820 |
Why?
|
Glycogen | 4 | 2023 | 251 | 0.810 |
Why?
|
Vulva | 2 | 2023 | 84 | 0.810 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2023 | 2421 | 0.800 |
Why?
|
Urinary Incontinence | 2 | 2023 | 490 | 0.770 |
Why?
|
Hydrogen Peroxide | 3 | 2015 | 731 | 0.770 |
Why?
|
Sexual Behavior | 6 | 2022 | 2189 | 0.760 |
Why?
|
Carrier State | 2 | 2015 | 522 | 0.750 |
Why?
|
Cytokines | 7 | 2024 | 7386 | 0.730 |
Why?
|
Chlamydia Infections | 2 | 2021 | 364 | 0.730 |
Why?
|
Estrogen Replacement Therapy | 4 | 2022 | 1208 | 0.720 |
Why?
|
Female | 98 | 2024 | 392544 | 0.720 |
Why?
|
HIV Infections | 15 | 2021 | 17347 | 0.700 |
Why?
|
Bacteroides | 1 | 2020 | 165 | 0.700 |
Why?
|
Lubricants | 1 | 2020 | 26 | 0.700 |
Why?
|
Sexually Transmitted Diseases | 3 | 2022 | 662 | 0.700 |
Why?
|
Administration, Intravaginal | 6 | 2021 | 149 | 0.700 |
Why?
|
Gonorrhea | 2 | 2021 | 346 | 0.690 |
Why?
|
Urinary Tract Infections | 3 | 2021 | 801 | 0.690 |
Why?
|
RNA, Viral | 6 | 2020 | 2839 | 0.680 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2015 | 2150 | 0.680 |
Why?
|
DNA, Viral | 4 | 2020 | 2195 | 0.670 |
Why?
|
Atrophy | 6 | 2023 | 1633 | 0.670 |
Why?
|
Urinary Tract | 1 | 2023 | 304 | 0.670 |
Why?
|
Sexual Dysfunctions, Psychological | 3 | 2022 | 190 | 0.660 |
Why?
|
Mucus | 1 | 2021 | 342 | 0.650 |
Why?
|
Epithelium | 2 | 2021 | 1603 | 0.640 |
Why?
|
Inflammation | 8 | 2024 | 10759 | 0.570 |
Why?
|
Genital Diseases, Female | 1 | 2018 | 192 | 0.560 |
Why?
|
Bodily Secretions | 2 | 2020 | 28 | 0.550 |
Why?
|
Escherichia coli Infections | 1 | 2020 | 518 | 0.540 |
Why?
|
Vulvovaginitis | 1 | 2016 | 14 | 0.530 |
Why?
|
Bacteria | 7 | 2023 | 2190 | 0.510 |
Why?
|
Humans | 100 | 2024 | 761208 | 0.500 |
Why?
|
Interleukin-8 | 3 | 2021 | 696 | 0.480 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1351 | 0.440 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2014 | 155 | 0.430 |
Why?
|
alpha-Defensins | 1 | 2012 | 30 | 0.420 |
Why?
|
beta-Defensins | 1 | 2012 | 59 | 0.420 |
Why?
|
Uterine Hemorrhage | 1 | 2014 | 240 | 0.420 |
Why?
|
Endometrium | 1 | 2014 | 403 | 0.390 |
Why?
|
Biofilms | 1 | 2016 | 625 | 0.390 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1920 | 0.380 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7407 | 0.370 |
Why?
|
Middle Aged | 33 | 2024 | 220853 | 0.350 |
Why?
|
Syndrome | 3 | 2023 | 3271 | 0.350 |
Why?
|
Anti-Retroviral Agents | 3 | 2015 | 1784 | 0.350 |
Why?
|
Premature Birth | 3 | 2021 | 1784 | 0.340 |
Why?
|
Desiccation | 1 | 2009 | 78 | 0.330 |
Why?
|
Chlamydia trachomatis | 2 | 2021 | 237 | 0.330 |
Why?
|
Women's Health | 2 | 2018 | 2070 | 0.330 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2244 | 0.320 |
Why?
|
Microbial Interactions | 2 | 2021 | 74 | 0.310 |
Why?
|
Cesarean Section | 4 | 2023 | 1399 | 0.310 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1448 | 0.290 |
Why?
|
Clomiphene | 1 | 2007 | 71 | 0.280 |
Why?
|
HIV Seronegativity | 1 | 2008 | 211 | 0.280 |
Why?
|
False Positive Reactions | 1 | 2009 | 958 | 0.280 |
Why?
|
Blood | 1 | 2009 | 596 | 0.280 |
Why?
|
Pregnancy | 16 | 2023 | 29893 | 0.280 |
Why?
|
Fertility Agents, Female | 1 | 2007 | 101 | 0.270 |
Why?
|
Adult | 33 | 2023 | 221119 | 0.270 |
Why?
|
Interleukin-1beta | 2 | 2013 | 1002 | 0.270 |
Why?
|
Viral Load | 3 | 2020 | 3328 | 0.270 |
Why?
|
Pregnancy Trimester, First | 2 | 2009 | 908 | 0.260 |
Why?
|
Young Adult | 18 | 2021 | 59221 | 0.250 |
Why?
|
Hot Flashes | 3 | 2020 | 330 | 0.250 |
Why?
|
Interleukin-6 | 2 | 2021 | 3210 | 0.250 |
Why?
|
Polymerase Chain Reaction | 6 | 2012 | 6067 | 0.240 |
Why?
|
Tablets | 2 | 2022 | 148 | 0.240 |
Why?
|
Specimen Handling | 1 | 2009 | 702 | 0.240 |
Why?
|
Metabolome | 2 | 2022 | 989 | 0.230 |
Why?
|
Double-Blind Method | 6 | 2022 | 12341 | 0.230 |
Why?
|
Amylases | 1 | 2023 | 171 | 0.220 |
Why?
|
Carbolines | 1 | 2024 | 295 | 0.200 |
Why?
|
Acetic Acid | 1 | 2021 | 59 | 0.200 |
Why?
|
Mycoplasma genitalium | 1 | 2021 | 12 | 0.190 |
Why?
|
Immunity, Mucosal | 2 | 2016 | 485 | 0.190 |
Why?
|
Sodium Bicarbonate | 1 | 2021 | 60 | 0.190 |
Why?
|
Glycerol | 1 | 2022 | 275 | 0.190 |
Why?
|
Mycoplasma Infections | 1 | 2021 | 120 | 0.190 |
Why?
|
Minnesota | 1 | 2021 | 337 | 0.190 |
Why?
|
Infertility, Female | 1 | 2007 | 761 | 0.180 |
Why?
|
Vaginal Smears | 2 | 2015 | 499 | 0.180 |
Why?
|
Quality of Life | 8 | 2024 | 13367 | 0.180 |
Why?
|
Mucous Membrane | 2 | 2014 | 659 | 0.180 |
Why?
|
Bacteriological Techniques | 2 | 2020 | 275 | 0.180 |
Why?
|
Aging | 2 | 2019 | 8702 | 0.180 |
Why?
|
Electronic Mail | 1 | 2022 | 213 | 0.180 |
Why?
|
Suburethral Slings | 1 | 2021 | 72 | 0.180 |
Why?
|
Dysmenorrhea | 1 | 2021 | 98 | 0.170 |
Why?
|
Ceftriaxone | 1 | 2021 | 175 | 0.170 |
Why?
|
Models, Biological | 1 | 2016 | 9457 | 0.170 |
Why?
|
Aged | 13 | 2024 | 169288 | 0.170 |
Why?
|
Kenya | 2 | 2013 | 756 | 0.170 |
Why?
|
Adolescent | 15 | 2021 | 88298 | 0.170 |
Why?
|
Pruritus | 1 | 2023 | 378 | 0.170 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 2 | 2010 | 23 | 0.170 |
Why?
|
Personality | 1 | 2023 | 553 | 0.160 |
Why?
|
Iodine | 1 | 2021 | 285 | 0.160 |
Why?
|
Antifungal Agents | 1 | 2024 | 752 | 0.160 |
Why?
|
Doxycycline | 1 | 2021 | 344 | 0.160 |
Why?
|
Microbial Viability | 1 | 2020 | 236 | 0.160 |
Why?
|
Neisseria gonorrhoeae | 1 | 2021 | 239 | 0.160 |
Why?
|
Bacterial Adhesion | 1 | 2020 | 304 | 0.160 |
Why?
|
Fecal Incontinence | 1 | 2021 | 242 | 0.150 |
Why?
|
Prevotella | 2 | 2017 | 80 | 0.150 |
Why?
|
Estriol | 1 | 2018 | 54 | 0.150 |
Why?
|
Prospective Studies | 15 | 2021 | 54435 | 0.150 |
Why?
|
Herpes Genitalis | 2 | 2024 | 149 | 0.150 |
Why?
|
Mucins | 1 | 2021 | 569 | 0.150 |
Why?
|
Coculture Techniques | 1 | 2021 | 1334 | 0.150 |
Why?
|
Gynecology | 1 | 2023 | 528 | 0.140 |
Why?
|
Gels | 1 | 2018 | 420 | 0.140 |
Why?
|
Delivery, Obstetric | 2 | 2021 | 941 | 0.140 |
Why?
|
Urinary Bladder | 1 | 2023 | 1152 | 0.140 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2019 | 246 | 0.130 |
Why?
|
Fatty Acids | 1 | 2024 | 1807 | 0.130 |
Why?
|
Longitudinal Studies | 3 | 2023 | 14610 | 0.130 |
Why?
|
Obstetrics | 1 | 2023 | 668 | 0.130 |
Why?
|
Immune System | 1 | 2021 | 792 | 0.130 |
Why?
|
Cohort Studies | 8 | 2019 | 41496 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 10218 | 0.130 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 236 | 0.130 |
Why?
|
Prevalence | 4 | 2019 | 15721 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2011 | 0.120 |
Why?
|
Megasphaera | 1 | 2014 | 2 | 0.120 |
Why?
|
Leptotrichia | 1 | 2014 | 13 | 0.120 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1936 | 0.120 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2018 | 489 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15841 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1812 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2021 | 64681 | 0.120 |
Why?
|
Actinobacteria | 1 | 2014 | 59 | 0.120 |
Why?
|
Placebo Effect | 1 | 2018 | 518 | 0.120 |
Why?
|
Molecular Typing | 1 | 2014 | 116 | 0.120 |
Why?
|
Cyclohexanols | 1 | 2014 | 126 | 0.110 |
Why?
|
Uterine Diseases | 1 | 2014 | 108 | 0.110 |
Why?
|
Washington | 2 | 2012 | 314 | 0.110 |
Why?
|
Drug Implants | 1 | 2014 | 230 | 0.110 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2024 | 360 | 0.110 |
Why?
|
Uterine Cervicitis | 1 | 2013 | 31 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3803 | 0.110 |
Why?
|
DNA, Bacterial | 3 | 2012 | 1470 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 927 | 0.100 |
Why?
|
Cell Survival | 1 | 2021 | 5778 | 0.100 |
Why?
|
Metabolomics | 1 | 2021 | 1658 | 0.090 |
Why?
|
Administration, Oral | 2 | 2009 | 4015 | 0.090 |
Why?
|
Bacterial Load | 1 | 2011 | 150 | 0.090 |
Why?
|
Microfluidics | 1 | 2016 | 651 | 0.090 |
Why?
|
Body Fluids | 1 | 2012 | 320 | 0.090 |
Why?
|
Cervix Mucus | 1 | 2010 | 18 | 0.090 |
Why?
|
Affect | 1 | 2018 | 1486 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2016 | 858 | 0.090 |
Why?
|
Homosexuality, Female | 1 | 2011 | 171 | 0.080 |
Why?
|
Environment | 1 | 2016 | 1122 | 0.080 |
Why?
|
Self Report | 2 | 2019 | 3727 | 0.080 |
Why?
|
Culture Media | 1 | 2011 | 894 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9616 | 0.080 |
Why?
|
Hysterectomy | 1 | 2014 | 857 | 0.080 |
Why?
|
Cytoplasm | 1 | 2014 | 1498 | 0.080 |
Why?
|
Regression Analysis | 2 | 2009 | 6345 | 0.080 |
Why?
|
Interleukin-1 | 1 | 2013 | 1250 | 0.080 |
Why?
|
Infant | 4 | 2023 | 36169 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1186 | 0.080 |
Why?
|
Pregnancy in Adolescence | 1 | 2010 | 163 | 0.080 |
Why?
|
United States | 7 | 2022 | 72339 | 0.080 |
Why?
|
Colony Count, Microbial | 1 | 2009 | 328 | 0.080 |
Why?
|
Models, Genetic | 1 | 2018 | 3430 | 0.070 |
Why?
|
Gestational Age | 3 | 2012 | 3580 | 0.070 |
Why?
|
Fungi | 1 | 2010 | 337 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1186 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2418 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1838 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2021 | 3952 | 0.070 |
Why?
|
Massachusetts | 2 | 2019 | 8837 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2020 | 3410 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2569 | 0.070 |
Why?
|
Menstrual Cycle | 1 | 2010 | 539 | 0.070 |
Why?
|
Clothing | 1 | 2007 | 96 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 828 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 26071 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2009 | 3418 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1520 | 0.060 |
Why?
|
Vacuum Curettage | 2 | 2002 | 44 | 0.060 |
Why?
|
Interleukins | 1 | 2010 | 782 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2007 | 525 | 0.060 |
Why?
|
Cultural Characteristics | 1 | 2007 | 250 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2009 | 14675 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2013 | 1390 | 0.060 |
Why?
|
Anti-Infective Agents | 1 | 2012 | 983 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4526 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2016 | 3671 | 0.060 |
Why?
|
Oleic Acid | 1 | 2024 | 92 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6180 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2854 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16575 | 0.050 |
Why?
|
Public Health | 1 | 2016 | 2672 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18384 | 0.050 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2022 | 53 | 0.050 |
Why?
|
Abortion, Incomplete | 1 | 2002 | 14 | 0.050 |
Why?
|
Recurrence | 2 | 2012 | 8457 | 0.050 |
Why?
|
Prenatal Care | 1 | 2010 | 1141 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5842 | 0.050 |
Why?
|
Mothers | 2 | 2023 | 2193 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18220 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58952 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22174 | 0.050 |
Why?
|
Genes, pol | 1 | 2020 | 52 | 0.050 |
Why?
|
Cells, Cultured | 1 | 2016 | 18926 | 0.040 |
Why?
|
Abortion, Legal | 1 | 2002 | 114 | 0.040 |
Why?
|
Genes, env | 1 | 2020 | 95 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2021 | 26199 | 0.040 |
Why?
|
Communication Barriers | 1 | 2023 | 414 | 0.040 |
Why?
|
DNA, Ribosomal | 2 | 2012 | 298 | 0.040 |
Why?
|
Menstruation | 1 | 2021 | 307 | 0.040 |
Why?
|
Therapeutic Irrigation | 1 | 2020 | 293 | 0.040 |
Why?
|
Urinary Incontinence, Stress | 1 | 2021 | 181 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 39957 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15637 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2021 | 311 | 0.040 |
Why?
|
Attitude to Health | 1 | 2007 | 2026 | 0.040 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 225 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 965 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39126 | 0.040 |
Why?
|
Semen | 1 | 2020 | 347 | 0.040 |
Why?
|
Vitamin D Deficiency | 1 | 2007 | 1388 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 888 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2022 | 610 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 80674 | 0.030 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 70 | 0.030 |
Why?
|
Risk Factors | 3 | 2022 | 74239 | 0.030 |
Why?
|
Abortion, Induced | 1 | 2002 | 462 | 0.030 |
Why?
|
Databases as Topic | 1 | 2018 | 473 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1490 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2475 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 42224 | 0.030 |
Why?
|
Rectum | 1 | 2020 | 891 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 4014 | 0.030 |
Why?
|
Adiponectin | 1 | 2021 | 1107 | 0.030 |
Why?
|
Body Image | 1 | 2019 | 639 | 0.030 |
Why?
|
Orgasm | 1 | 2014 | 62 | 0.030 |
Why?
|
Breast Feeding | 1 | 2022 | 1356 | 0.030 |
Why?
|
Child | 2 | 2021 | 80152 | 0.030 |
Why?
|
Self Concept | 1 | 2019 | 1046 | 0.030 |
Why?
|
Perimenopause | 1 | 2014 | 142 | 0.030 |
Why?
|
Virus Replication | 1 | 2020 | 2426 | 0.030 |
Why?
|
Peru | 1 | 2015 | 888 | 0.030 |
Why?
|
Animals | 3 | 2024 | 168079 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2545 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12976 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3134 | 0.020 |
Why?
|
South Africa | 1 | 2017 | 1843 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2024 | 3836 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1081 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2420 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4739 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8642 | 0.020 |
Why?
|
Emotions | 1 | 2019 | 2742 | 0.020 |
Why?
|
Africa, Eastern | 1 | 2007 | 76 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2010 | 12052 | 0.020 |
Why?
|
Insulin | 1 | 2021 | 6588 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5871 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22127 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8247 | 0.010 |
Why?
|
Probability | 1 | 2010 | 2478 | 0.010 |
Why?
|
Computer Simulation | 1 | 2018 | 6224 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2928 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4372 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81326 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 2007 | 397 | 0.010 |
Why?
|
Logistic Models | 2 | 2010 | 13249 | 0.010 |
Why?
|
Anxiety | 1 | 2018 | 4569 | 0.010 |
Why?
|
Abortion, Missed | 1 | 2002 | 12 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7400 | 0.010 |
Why?
|
Adolescent Behavior | 1 | 2010 | 1188 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10553 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23416 | 0.010 |
Why?
|
Health Education | 1 | 2007 | 1049 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2688 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2923 | 0.010 |
Why?
|
Family Planning Services | 1 | 2002 | 267 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8132 | 0.010 |
Why?
|
Pathology, Clinical | 1 | 2002 | 376 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9652 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3200 | 0.010 |
Why?
|
Health Status | 1 | 2007 | 4077 | 0.010 |
Why?
|
Vitamin D | 1 | 2007 | 3301 | 0.010 |
Why?
|
Health Surveys | 1 | 2002 | 4037 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21365 | 0.010 |
Why?
|
Male | 2 | 2020 | 360693 | 0.010 |
Why?
|
Health Care Costs | 1 | 2002 | 3239 | 0.000 |
Why?
|
Risk Assessment | 1 | 2010 | 24021 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15308 | 0.000 |
Why?
|